Multiple Cutaneous Metastasis of Synchronous Urothelial Carcinoma of the Bladder and The Renal Pelvis

A Case Report

M. Ghalleb; M. A. Ayadi; S. Slim; I. Zemni; R. Doghri; J. Ben Hassouna; K. Rahal

Disclosures

J Med Case Reports. 2019;13(34) 

In This Article

Abstract and Introduction

Abstract

Introduction: Cutaneous metastatic disease arising from urinary tract carcinoma is rare and associated with a poor prognosis. We report a case of metastatic disease occurring in a patient treated for synchronous urothelial tumor of the bladder and left renal pelvis.

Case presentation: A 61-year-old Caucasian man was treated for a synchronous urothelial tumor of the bladder and left renal pelvis. He had an en bloc radical cystectomy and left ureteronehprectomy associated with a cutaneous transileal urinary diversion and lymph node dissection. He was scheduled for chemotherapy but was lost to follow-up. He consulted 1 year later with growing skin tumors that were confirmed to be metastatic disease, and he was referred to the oncology department for palliative chemotherapy.

Conclusion: Cutaneous metastatic disease is a rare entity with poor prognosis. The main treatment remains chemotherapy; however, single-site metastasis should be considered for metastasectomy.

Introduction

Cutaneous metastatic disease (CMD) arising from primary visceral carcinoma is rare, occurring with an overall incidence of 0.3% to 5.3%.[1,2] Urologic cancers appear less likely than other primary malignancies to metastasize to the skin, with an incidence of 0.73%.[2] We report a case of multiple-site skin metastasis in a patient followed for synchronous urothelial carcinoma of the bladder and the left renal pelvis. This work is reported using the care checklist guidelines.

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....